Wang Menghui, Xie Chuan
Department of Gastroenterology, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Front Genet. 2022 Aug 12;13:931866. doi: 10.3389/fgene.2022.931866. eCollection 2022.
DNA in cells is frequently damaged by endogenous and exogenous agents. However, comprehensive mechanisms to combat and repair DNA damage have evolved to ensure genomic stability and integrity. Improper DNA damage repair may result in various diseases, including some types of tumors and autoimmune diseases. Therefore, DNA damage repair mechanisms have been proposed as novel antitumor drug targets. To date, numerous drugs targeting DNA damage mechanisms have been developed. For example, PARP inhibitors that elicit synthetic lethality are widely used in individualized cancer therapies. In this review, we describe the latent DNA damage repair mechanisms in gastric cancer, the types of DNA damage that can contribute to the development of gastric cancer, and new therapeutic approaches for gastric cancer that target DNA damage repair pathways.
细胞中的DNA经常受到内源性和外源性因素的损伤。然而,为确保基因组稳定性和完整性,对抗和修复DNA损伤的综合机制已经进化形成。DNA损伤修复不当可能导致各种疾病,包括某些类型的肿瘤和自身免疫性疾病。因此,DNA损伤修复机制已被提议作为新型抗肿瘤药物靶点。迄今为止,已经开发出许多针对DNA损伤机制的药物。例如,引发合成致死性的PARP抑制剂被广泛用于个体化癌症治疗。在这篇综述中,我们描述了胃癌中潜在的DNA损伤修复机制、可能促成胃癌发生的DNA损伤类型,以及针对DNA损伤修复途径的胃癌新治疗方法。